Oxcarbazepine Suspension
Product Images NDC 68999-841

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68999-841). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Governmental & Specialty Rx, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Graph 1)

A line graph showing the exit rate over time for two treatment groups: Oxcarbazepine and Placebo. The x-axis represents days on trial from Day 2 to Day 11, and the y-axis represents the exit rate from 0 to 1. The solid line indicates Oxcarbazepine group's exit rate, while the dotted line represents the Placebo group. The graph includes a log-rank test p-value of 0.0001, indicating a statistically significant difference between the groups.*

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Graph 2)

A Kaplan-Meier curve showing seizure rate over days from first dose to first seizure, comparing two treatment groups: Oxcarbazepine and Placebo. The chart includes a log-rank test p-value of 0.046, indicating a statistical comparison between the groups.*

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Graph 3)

A Kaplan-Meier survival curve chart showing exit ratios over time (days) for two treatment groups labeled HIGH and LOW. The X-axis represents time to exit in days, while the Y-axis represents the exit ratio. The LOW group has a higher and faster exit rate than the HIGH group. A log-rank test p-value of 0.0001 is displayed, indicating statistical comparison between groups.*

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Graph 4)

A survival curve chart depicting exit rates over time in days for two treatment groups labeled High and Low. The y-axis represents the exit rate from 0.0 to 1.0, and the x-axis shows time to exit up to 130 days. The chart includes a log-rank test p-value of 0.0001 comparing the groups.*

FDA Label Image

Image Description (Oxycarbazepine Oral Suspension Structure)

Chemical structure diagram of Oxcarbazepine showing its molecular framework with ring structures and characteristic functional groups.*

FDA Label Image

Oxcarbazepine Oral Suspension, Usp 300 mg/5 mL (NDC 68999-841-45)

Round label for Oxcarbazepine oral suspension, USP, 300 mg/5 mL strength. The label indicates a 5 mL delivery volume, includes the NDC 68999-841-45, and notes 'Shake well before using.' It is marked for institutional use only and manufactured by Chartwell Governmental & Specialty RX, LLC, Congers, NY. Additional info includes lot number and expiration date fields, along with instructions to see the insert or medguide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.